[Paper Review] Generalization in medical AI: a perspective on developing scalable models

Zvuloni, Eran, Leo Anthony Celi+1 more|arXiv (Cornell University)|Nov 9, 2023

Machine Learning in Healthcare4 citations

TL;DR

This paper introduces a three-level framework to assess out-of-distribution generalization in medical AI, categorizing model performance based on data availability and domain shift. It provides a structured approach for researchers to evaluate and improve scalability of medical AI models across diverse clinical settings.

ABSTRACT

The scientific community is increasingly recognizing the importance of generalization in medical AI for translating research into practical clinical applications. A three-level scale is introduced to characterize out-of-distribution generalization performance of medical AI models. This scale addresses the diversity of real-world medical scenarios as well as whether target domain data and labels are available for model recalibration. It serves as a tool to help researchers characterize their development settings and determine the best approach to tackling the challenge of out-of-distribution generalization.

Motivation & Objective

• Address the critical challenge of out-of-distribution generalization in medical AI, which hinders real-world clinical deployment.
• Recognize that current evaluation methods fail to capture the full spectrum of real-world medical data variability and deployment conditions.
• Develop a standardized scale to characterize model generalization performance under varying degrees of domain shift and data availability.
• Guide researchers in selecting appropriate strategies for model development and calibration based on target domain data and label availability.
• Promote the creation of scalable, robust medical AI systems that perform reliably across diverse healthcare environments.

Proposed method

• Propose a three-level scale to classify out-of-distribution generalization performance in medical AI models.
• Level 1: Models evaluated on data from the same distribution as training data, with no domain shift.
• Level 2: Models tested on out-of-distribution data without access to target domain labels for recalibration.
• Level 3: Models evaluated on out-of-distribution data with access to target domain labels for fine-tuning or recalibration.
• Use this framework to guide model development, selection, and evaluation based on real-world deployment constraints.
• Frame the scale as a diagnostic tool to help researchers align model design with clinical deployment realities.

Experimental results

Research questions

• RQ1 How can generalization performance of medical AI models be systematically categorized across varying degrees of domain shift?
• RQ2 What role does access to target domain labels play in improving out-of-distribution generalization?
• RQ3 How can researchers select appropriate model development strategies based on data availability and deployment context?
• RQ4 In what ways does the three-level framework improve the scalability and clinical translatability of medical AI systems?
• RQ5 How does the framework support the transition from research models to real-world clinical applications?

Key findings

• The three-level framework provides a standardized way to characterize out-of-distribution generalization, improving clarity in model evaluation.
• Models in Level 2 (no target labels) face significant performance degradation when deployed in new domains, highlighting the need for robust domain adaptation.
• Models in Level 3 (with target labels) show improved generalization, indicating that access to domain-specific data enables effective recalibration.
• The framework enables researchers to identify the most appropriate development strategy based on deployment constraints and data availability.
• By aligning model development with real-world clinical settings, the framework enhances the likelihood of successful clinical translation.
• The approach supports scalable model development by systematically addressing the challenges of data diversity and distribution shift.